There were 17 deaths in the fluvoxamine group and 25 deaths in the placebo group in the primary intention-to-treat analysis (odds ratio [OR] 0·68, 95% CI: 0·36–1·27). There was one death in the fluvoxamine group and 12 in the placebo group for the per-protocol population (OR 0·09; 95% CI 0·01–0·47). 

I don’t call that too modest…

I mean, it even looks like fluoxetine works… so I’ll be surprised if we find out it’s a dud. SSRIs in general 

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2786136

This doc is really screaming to the rooftops daily about fluvoxamine (and other potential treatments) and explains  mechanisms of action, this is just one example 

https://twitter.com/farid__jalali/status/1304829175220465665?s=20